Literature DB >> 4091531

Susceptibility of Campylobacter jejuni and Campylobacter coli to macrolides and related compounds.

Z Elharrif, F Mégraud, A M Marchand.   

Abstract

The susceptibility of 105 thermophilic campylobacters from human and swine origins to eight macrolides and related compounds was tested. Erythromycin, josamycin, clindamycin, and ASE 136 BS (a new erythromycin derivative) were the most active against the human strains. The swine strains were highly resistant, except to pristinamycin. The human Campylobacter coli strains (except for two strains) behaved like the C. jejuni strains.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4091531      PMCID： PMC176361          DOI： 10.1128/AAC.28.5.695

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  22 in total

1.  Susceptibility of related vibrios and Vibrio fetus to twelve antibiotics.

Authors:  J P Butzler; P Dekeyser; T Lafontaine
Journal:  Antimicrob Agents Chemother       Date:  1974-01       Impact factor: 5.191

2.  Susceptibility testing of Campylobacter fetus subsp. jejuni, using broth microdilution panels.

Authors:  G E Buck; M T Kelly
Journal:  Antimicrob Agents Chemother       Date:  1982-02       Impact factor: 5.191

3.  Susceptibility pattern of Campylobacter jejuni from human and animal origins to different antimicrobial agents.

Authors:  R Vanhoof; H Goossens; H Coignau; G Stas; J P Butzler
Journal:  Antimicrob Agents Chemother       Date:  1982-06       Impact factor: 5.191

4.  Susceptibility of Campylobacter fetus subsp. jejuni, isolated from patients in Jakarta, Indonesia to ten antimicrobial agents.

Authors:  S Ringertz; R C Rockhill; O Ringertz
Journal:  J Antimicrob Chemother       Date:  1981-10       Impact factor: 5.790

5.  Antimicrobial susceptibility of Campylobacter jejuni isolated from humans with diarrhoea and from healthy chickens.

Authors:  A Svedhem; B Kaijser; E Sjögren
Journal:  J Antimicrob Chemother       Date:  1981-03       Impact factor: 5.790

6.  Susceptibility of Campylobacter fetus subsp. jejuni to twenty antimicrobiol agents.

Authors:  M Walder
Journal:  Antimicrob Agents Chemother       Date:  1979-07       Impact factor: 5.191

7.  Antimicrobial susceptibility of Campylobacter jejuni with special reference to resistance patterns of Canadian isolates.

Authors:  M A Karmali; S De Grandis; P C Fleming
Journal:  Antimicrob Agents Chemother       Date:  1981-04       Impact factor: 5.191

8.  Hippurate hydrolysis by Campylobacter fetus.

Authors:  S M Harvey
Journal:  J Clin Microbiol       Date:  1980-04       Impact factor: 5.948

9.  In vitro activities of 47 antimicrobial agents against three Campylobacter spp. from pigs.

Authors:  C J Gebhart; G E Ward; H J Kurtz
Journal:  Antimicrob Agents Chemother       Date:  1985-01       Impact factor: 5.191

10.  In vitro susceptibility of Campylobacter fetus subsp. jejuni to N-formimidoyl thienamycin, rosaramicin, cefoperazone, and other antimicrobial agents.

Authors:  V I Ahonkhai; C E Cherubin; M F Sierra; V D Bokkenheuser; M A Shulman; A C Mosenthal
Journal:  Antimicrob Agents Chemother       Date:  1981-12       Impact factor: 5.191
View more
  9 in total

Review 1.  New directions for macrolide antibiotics: structural modifications and in vitro activity.

Authors:  H A Kirst; G D Sides
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

2.  Susceptibility of Campylobacter pyloridis to 20 antimicrobial agents.

Authors:  T Lambert; F Mégraud; G Gerbaud; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1986-09       Impact factor: 5.191

3.  Antimicrobial resistance of Campylobacter jejuni and Campylobacter coli with special reference to plasmid profiles of Japanese clinical isolates.

Authors:  H Sagara; A Mochizuki; N Okamura; R Nakaya
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

4.  In vitro susceptibility of Campylobacter jejuni to rokitamycin.

Authors:  Y Miyake; M Okada; M Sasaki; N Nagasaka; H Suginaka
Journal:  Antimicrob Agents Chemother       Date:  1990-07       Impact factor: 5.191

5.  In vitro activity of dirithromycin (LY 237216) compared with activities of other macrolide antibiotics.

Authors:  K W Yu; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

6.  Characterization of the porins of Campylobacter jejuni and Campylobacter coli and implications for antibiotic susceptibility.

Authors:  W J Page; G Huyer; M Huyer; E A Worobec
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

7.  Synthesis and antimicrobial evaluation of dirithromycin (AS-E 136; LY237216), a new macrolide antibiotic derived from erythromycin.

Authors:  F T Counter; P W Ensminger; D A Preston; C Y Wu; J M Greene; A M Felty-Duckworth; J W Paschal; H A Kirst
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

8.  Erythromycin-resistant Campylobacter infections in Thailand.

Authors:  D N Taylor; M J Blaser; P Echeverria; C Pitarangsi; L Bodhidatta; W L Wang
Journal:  Antimicrob Agents Chemother       Date:  1987-03       Impact factor: 5.191

Review 9.  Dirithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  R N Brogden; D H Peters
Journal:  Drugs       Date:  1994-10       Impact factor: 9.546
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.